Testing laboratory · Reviewed 2026-09-03
Anresco Laboratories · Commerce, California, USA
Legitimacy review
Anresco has the strongest general institutional history in this directory. That does not automatically establish accredited peptide identity, purity, or quantity work; the reviewed scope covers enumerated pharmaceutical, food, cannabis, metals, solvent, and microbiological methods.
Anresco, Inc. dba Anresco Laboratories identifies multigenerational Eisenberg leadership. Its current certificate uses 5400 Jillson St, Commerce, California, while official marketing still describes a San Francisco headquarters and additional branches.
More than eight decades of operation, named leadership, current ANAB scope, FDA establishment record, and multiple established facilities.
ANAB AT-1551.01 is valid through June 29, 2027. The scope includes specified LC-MS/MS, GC-MS, LC-DAD, ICP-MS, and microbiology work but does not expressly list peptide identity, assay, or chromatographic purity.
Anresco provides broad analytical testing across food, pharmaceutical, cannabis, environmental, and related matrices. Published general turnaround is about 10-to-15 working days; pricing is quote-based.
A small older review set includes both positive comments and service complaints. The volume and age are inadequate for a current quality determination.
Peptide methods are not expressly in the reviewed accredited scope, and Commerce-versus-San-Francisco location copy needs reconciliation. General laboratory stature does not transfer accreditation to an unlisted peptide method or matrix.
COA verification
Authenticated client portal or direct confirmation from Anresco.
Result handling
Use only when the official destination returns the same identifier and the material certificate fields agree.
Use only after a functioning official lookup explicitly returns no record for the submitted identifier.
Use when the official destination resolves the identifier but returns a different report, product, batch, or other material identity field.
CAPTCHA, login, timeout, rate limit, outage, or an unusable response remains portal unavailable, not an invalid certificate.
Anresco is reference-only in the fixed checker; retained documents must remain document-only until an official report response is captured.
Use when the issuer identity, required identifier, or official workflow cannot be established from the available evidence.
Certificate structure
Retain and review every page; the fixed checker has no Anresco record with which to validate current page handling.
Treat each reported method and panel independently and do not infer unreported tests from the laboratory's broader capabilities.
Evidence boundaries
Review receipts
No representative record is retained in the current snapshot.
Public search record
Current results are led by Anresco's official site, accreditation documents, regulatory listings, and local-business reviews. Peptide-specific review coverage is thin, creating room for a narrowly evidenced identity-and-verification guide.
Sources
Reusable integration rule: For future Anresco integrations, retain the complete report and its printed report identifier, label the route client-authenticated, and publish verified status only after an exact issuer response.
Check the document
